Fold Holdings, Inc. Warrant is a biotechnology firm committed to developing innovative therapeutic solutions for rare genetic disorders. The company boasts a robust pipeline of proprietary drug candidates that are currently progressing through clinical development, underscoring its dedication to addressing significant unmet medical needs. With a clear focus on innovation and transformative treatment approaches, Fold Holdings presents an attractive opportunity for institutional investors looking to diversify their portfolios within the biopharmaceutical sector, especially as it targets…